NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.
New Healthcare-related Products, Services, and Companies Featured Briefs: Pharma Industry Veteran Launches Online Recruitment Site FlightPath Enables Interactive Commercialization Planning Expanded SDI Media Services Measure Pharma Ad Campaign ROI New Team Aligns Parexel Experts With Biopharma Counterparts Cadient Launches Interactive Strategies Consulting Group Quintiles Adds Patient-Centric CME Model New Integrated Marketing Solutions Company is Formed Sidebars: Around the Globe On The Shelves Follow up CADIENT GROUP is an interactive marketing network focused on the healthcare industry. For more information, visit cadient.com. INVENTIV HEALTH INC. delivers customized clinical, sales, marketing, and communications solutions through four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. For more information, visit inventivhealth.com. MedTera is an integrated marketing solutions partner dedicated to improving education, promotion, and communications in the life-sciences and pharmaceutical industries. For more information, visit medterasolutions. PAREXEL INTERNATIONAL CORP. is a global biopharmaceutical services organization providing a broad range of knowledge-based contract research, medical communications, and consulting services. For more information, visit parexel.com. PHARMSTORM is an online job search and recruitment resource for the pharmaceutical industry. For more information, visit pharmstorm.com. QUINTILES MEDICAL EDUCATION is the continuing medical education arm of Quintiles. For more information, visit quintiles.com. SDI is a healthcare market insight and analytics firm. For more information, visit sdihealth.com. Henry Stewart Publications’ new peer-reviewed JOURNAL OF COMMUNICATION IN HEALTHCARE includes articles, research, and case studies on how to improve communication with patients, the public, and the media. It offers guidance and lessons learned from fellow professionals; examinations of innovative strategies, techniques, and campaigns; insights from healthcare insiders such as clinicians, providers, and charities; input from influential policymakers; and guidance on best practices from PR, marketing, brand management, sales, and other professionals. For more information, visit henrystewart.com/jch. Informa Healthcare’s Good Clinical Practice journal has been relaunched as SCRIP CLINICAL RESEARCH, offering readers a shift in content from the theoretical to the practical business of clinical trials. In addition to a bimonthly hardcopy publication, Scrip Clinical Research features a Web site that provides users with the latest breaking news, clinical research, drug trial, and company information, and links to relevant material from Scrip and other Informa Pharma newsletter content. For more information, visit scripclinicalresearch.com. KANTAR HEALTH is expanding its CardioMonitor cardiovascular and diabetes patient database service into Japan and China. The new information service helps pharmaceutical and biotech companies size opportunities, identify treatment dynamics, position products, and sharpen forecasts in the growing Japanese and Chinese markets. For more information, visit kantarhealth.com. MERCK SERONO, a division of Merck KGaA, has established a global R&D center in Beijing to lead drug development for China and other Asian countries, both for local clinical trials and participation in global clinical trials. The Merck Serono China team is also responsible for managing Merck Serono’s collaborations with research institutions in China and continuing to look for partnerships with local academic institutions and companies. Research activities conducted in the China R&D center focus mainly on biomarker research, including pharmacogenomics and bioanalytics activities. For more information, visit merckserono.com. Global contract research organization PPD has expanded its presence in China through the acquisition of BioDuro LLC, a Beijing-based drug discovery outsourcing company that provides a broad range of integrated services to biopharmaceutical companies. The acquisition brings PPD’s total staff in China to almost 1,000, making it the largest CRO to offer clinical development and discovery services in the country. For more information, visit ppdi.com. PRA INTERNATIONAL has moved its Seoul office to a larger, more centrally located facility to accommodate the CRO’s rapid growth and further broaden its ability to deliver clinical service excellence in South Korea. For more information, visit prainternational.com. International pharmaceutical and medical device services company PREMIER RESEARCH GROUP has expanded its functional sourcing resources to Eastern Europe. Premier Research is providing these low-cost data processing services through experienced professionals based in the company’s existing offices in Bulgaria and Slovakia. For more information, visit premier-research.com. In response to requests from clients, SCHULMAN ASSOCIATES IRB has expanded its institutional review board services into Canada. For North American studies conducted in both the United States and Canada, Schulman’s Canadian and U.S. board members are reviewing the research together in order to maintain consistency. Schulman’s Canadian office is located in Toronto. For more information, visit sairb.com. SUDLER & HENNESSEY has partnered with longtime healthcare industry veteran Martin Sherwood to establish an agency in Johannesburg. Sherwood Sudler & Hennessey serves as a hub to deliver advertising and promotional needs for pharmaceutical and healthcare agencies in the greater South Africa region. For more information, visit sudler.com. TAKEDA PHARMACEUTICALS NORTH AMERICA has incorporated Takeda Pharmaceuticals Mexico S.A. de C.V., strengthening the company’s North American presence and bolstering existing operations in the United States and Canada. Takeda Pharmaceuticals Mexico has headquarters in Mexico City. For more information, visit tpna.com. ZS ASSOCIATES has opened an office in Barcelona to help clients across Spain and Portugal improve their commercial sales organizations in the face of the constantly evolving global healthcare market. Stefano DeSantis, office managing principal for the ZS office in Milan, also serves as the office managing principal for the Barcelona office. For more information, visit zsassociates.com. PharmStorm is a newly launched online resource with the goal of meeting both job search and recruitment needs by using a proprietary algorithm and multidimensional criteria to identify top-level candidates and present them to companies recruiting for positions ranging from entry level to C-level, research to sales, and management to production. Despite the fact that the pharmaceutical industry’s job outlook is one of the few that has not been decimated by the economic downturn, the recruitment process is not without its frustrations. This difficulty in finding efficient search and placement resources prompted Founder and President Maryellen Ruvolo, a 27-year pharma industry veteran, to develop the PharmStorm platform. “After many years in the industry, I saw many of my colleagues, highly qualified professionals, having great difficulty finding positions,” Ms. Ruvolo notes. “I knew the industry needed a more sophisticated resource, one which relied on advanced technologies and was driven by practical business strategies.” PharmStorm’s proprietary back-end software enables candidates to present their various qualifications and maximize their potential to find the right job. Candidates can track interest in their qualifications, select which companies their profiles are sent to, modify their resumes and profiles for maximum exposure and contact, and determine how their qualifications measure up to others. On the corporate side, the companies expressed increasing frustration with the methods and costs associated with employee recruitment, says Maryellen Ruvolo. inVentiv Health’s FlightPath is an organizing platform for commercialization planning that provides healthcare companies with access to strategic insights, planning expertise, and tactical execution capabilities coordinated through a single point of contact. “Even the most innovative compounds can fail to achieve commercial success without well-developed strategies, aligned tactics, and carefully coordinated execution,” says Norman Stalsberg, president of inVentiv Advance Insights. “FlightPath is a tailored commercialization approach designed to help healthcare executives navigate the process with confidence, regardless of whether their product is still in early development, relaunching after being on the market for years, or somewhere in between.” FlightPath is structured around four key planning disciplines: • Commercialization strategy, which includes defining the business opportunity, establishing positioning, and setting strategies, goals, priorities and critical success factors; • Commercialization planning, which includes the construction of a detailed cross-functional tactical plan and encompasses specific timelines and budgets, roles, and responsibilities of team members; • Implementation, which includes execution of plan tactics through inVentiv’s teams of marketing and sales experts; and • Monitoring and reporting, which provides continuous progress monitoring and feedback and the identification of necessary planning modifications and adjustments. Launching new products in today’s complex market can be extremely daunting, observes Norman Stalsberg. New service provides clients with customized, interactive approach to commercialization planning and execution. SDI’s expanded Media Innovations division brings comprehensive de-identified patient-level data and pharmaceutical industry analytics to media and advertising agency companies, providing reporting on audience quality and products to measure campaign ROI. HealthRatings allows media and advertising companies to profile the actual healthcare behavior of specific television, magazine, and online audiences using de-identified patient-level data. For each audience, HealthRatings includes data on the conditions they suffer from, the drugs they take, and treatment compliance. Media companies and advertising agencies can use this information to effectively target the right audience and create relevant messages. “SDI’s Media Innovations offers an approach that addresses two of the most challenging issues for advertising pharmaceutical brands — reaching the right patient targets and determining campaign ROI — provided in language that the pharmaceutical companies already understand,” says Dave Nussbaum, VP of SDI’s Media Innovations division. “Media companies that profile and measure audience behavior according to their clients’ standards will have a distinct advantage.”Parexel’s recently established The Expert Office is focused on delivering a new level of strategic partnership based on program design expertise, operational excellence, and project leadership. “Biopharmaceutical companies face myriad regulatory, medical, and scientific issues that are changing the clinical development environment, and Parexel is committed to easing these challenges,” says Mark Goldberg, M.D., Parexel’s chief operating officer. The Expert Office is comprised of top specialists in their fields, many of whom are former regulators, pharmaceutical company executives, and leaders of medical institutes who draw on their regulatory, business, and scientific experience. “This consolidation of knowledge throughout the life cycle of a program is focused on helping companies make faster, better-informed development and commercialization decisions and accelerate clinical research,” observes Udo Kiessling, M.D., corporate VP and chief medical officer.